About Columbia Regional
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Columbia Regional
During the past decade, Columbia Regional conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 24 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 12 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
2001-10-18
Active, not recruiting
1,449
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
2003-12-29
2021-03-31
Completed
3,154
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
2004-03-22
Recruiting
3,885
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2005-04-11
2021-03-31
Completed
5,377
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
2006-10-30
2024-12-31
Active, not recruiting
808
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
2007-03-26
2028-07-30
Active, not recruiting
379
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
2007-01-22
Active, not recruiting
1,895
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
2008-01-14
2023-07-20
Active, not recruiting
218
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Regional"
#1 collaborator was "National Cancer Institute (NCI)" with 44 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Columbia Regional
According to Clinical.Site data, the most researched conditions in "Columbia Regional" are
"Acute Lymphoblastic Leukemia" (8 trials), "Acute Myeloid Leukemia" (5 trials), "B Acute Lymphoblastic Leukemia" (5 trials), "Osteosarcoma" (5 trials) and "Ganglioneuroblastoma" (4 trials). Many other conditions were trialed in "Columbia Regional" in a lesser frequency.
Clinical Trials Intervention Types at Columbia Regional
Most popular intervention types in "Columbia Regional" are "Other" (48 trials), "Drug" (40 trials), "Biological" (17 trials), "Procedure" (17 trials) and "Radiation" (17 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Cyclophosphamide" (25 trials), "Vincristine Sulfate" (24 trials), "Doxorubicin Hydrochloride" (18 trials) and "Etoposide" (17 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia Regional
The vast majority of trials in "Columbia Regional" are
60 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Columbia Regional
Currently, there are NaN active trials in "Columbia Regional".
undefined are not yet recruiting,
20 are recruiting,
28 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Columbia Regional,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Columbia Regional, 1 "Phase 1"
clinical trials were conducted, 12 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".